| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Poisoning by digoxin |
Causative agent |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Accidental overdose of digoxin |
Causative agent |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Digoxin blood measurement |
Component |
False |
Digoxin (substance) |
Inferred relationship |
Some |
2 |
| Digoxin measurement |
Component |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Serum digoxin measurement |
Component |
False |
Digoxin (substance) |
Inferred relationship |
Some |
2 |
| Accidental digoxin poisoning (disorder) |
Causative agent |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| Intentional digoxin poisoning |
Causative agent |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| forgiftning med digoxin, uvist med hvilken hensigt |
Causative agent |
False |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Allergy to digoxin (finding) |
Causative agent |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| Digoxin overdose |
Causative agent |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Intentional digoxin overdose |
Causative agent |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| overdosis af digoxin, uvist med hvilken hensigt |
Causative agent |
False |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 62.5 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| digoxin 100 µg/1 ml injektionsvæske til børn |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| digoxin 50 µg/ml pædiatrisk oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| digoxin 250 µg/ml injektionsvæske, opløsning, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| Digoxin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Digoxin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Digoxin 0.125mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| Digoxin 0.25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| Digoxin 38mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely digoxin 100 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely digoxin 50 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| digoxin 0,1 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely digoxin 200 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| Digitalis (substance) |
Is a |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| Product containing digoxin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| digoxin-antistof Fab-fragment 38 mg/hætteglas, pulver til injektionsvæske, 4 ml hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| Plasma digoxin measurement (procedure) |
Component |
False |
Digoxin (substance) |
Inferred relationship |
Some |
2 |
| Digoxin 125 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| Digoxin 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| Digitalis-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| digoxin 50 µg/ml pædiatrisk eliksir til oral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
|
| Accidental digoxin poisoning (disorder) |
Causative agent |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Intentional digoxin poisoning |
Causative agent |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Digoxin adverse reaction |
Causative agent |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Administration of prophylactic digoxin (procedure) |
Direct substance |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Administration of prophylactic digoxin (procedure) |
Direct substance |
False |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Allergy to digoxin (finding) |
Causative agent |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 62.5 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 62.5 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Digoxin 125 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Digoxin 125 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Digoxin 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Digoxin 250 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 100 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 100 microgram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 50 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 50 microgram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 200 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 200 microgram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 100 microgram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Digoxin 250 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 50 microgram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 62.5 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Digoxin 125 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 200 microgram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 500 microgram/2 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 500 microgram/2 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 50 microgram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 50 microgram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 100 microgram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely digoxin 100 microgram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only digoxin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only digoxin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Digoxin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Digoxin 100 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Digoxin 100 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Digoxin 250 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Digoxin 250 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Digoxin blood measurement |
Component |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Plasma digoxin measurement (procedure) |
Component |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
| Serum digoxin measurement |
Component |
True |
Digoxin (substance) |
Inferred relationship |
Some |
1 |
FHIR